Search for the product you’re interested in.
Search by Index
Search results for 'Prescription Drugs'
  • Prophylaxis of Japanese encephalitis
  • Improvement of dizziness caused by chronic cerebral circulation disorder following cerebral infarction
  • Once-daily subcutaneous administration for the treatment of adult and pediatric patients with type 1 diabetes mellitus or adult patients with type 2 diabetes mellitus who require basal (long-acting) insulin for the control of hyperglycemia.
  • 1) Management of edema associated with heart failure (i.e. congestive heart failure), cirrhosis of the liver (i.e. ascites), or renal disease; acute pulmonary edema 2) Management of essential or renal hypertension
  • 1) Management of edema associated with heart failure (i.e. congestive heart failure), cirrhosis of the liver (i.e. ascites), or renal disease; peripheral vascular edema 2) Management of essential or renal hypertension
  • Hyperlipidemia: hypercholesterolemia (type IIa), combined type of hypercholesterolemia and hypertriglyceridemia (type IIb, type III), hypertriglyceridemia (type IV)
  • Hyperlipidemia: hypercholesterolemia (type IIa), combined type of hypercholesterolemia and hypertriglyceridemia (type IIb, type III), hypertriglyceridemia (type IV)
  • Primary hypercholesterolemia: As an adjuvant to diet to reduce elevated total-cholesterol, LDL-cholesterol, apolipoprotein-B, triglycerides and non-HDL-cholesterol, and to increase HDL-cholesterol in patients with primary hypercholesterolemia (heterozygous familial and nonfamilial) or mixed dyslipidemia
  • Active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135. Menactra is approved for use in individuals 9 months through 55 years of age
맨위로